News
The study found that weight regain varied with follow-up, with participants experiencing weight regain at eight, 12, and 20 ...
To improve access to care, many professional organizations have advocated for classifying obesity as a disease. However, the idea remains controversial, fueling one of the most polarizing debates in ...
4h
News Medical on MSNChinese study shows lasting weight loss after tirzepatide treatmentObesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, hypertension, and cardiovascular disease.
Scientists found that obesity may exist in 11 biological forms, each linked to different genes and body functions.
Obesity is the largest epidemic worldwide that reportedly kills people of all ages. This deadly disease currently affects more than 2 billion people worldwide. Due to changing food systems and ...
Significant’ weight returned weeks after stopping drug, say researchers who advise patients to adjust expectations.
Men receiving tirzepatide showed greater reductions in body weight and waist circumference and improvements in erectile ...
For decades, obesity treatment has leaned on temporary fixes—diets, medications, and weight-loss fads. Today, nearly 12 percent of U.S. adults have used a GLP-1 drug.
Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...
Pediatricians should screen children with obesity for those and other conditions at routine checkups, the AAP said in the new guidelines. Reducing BMI with treatment can help prevent those other ...
Technology alone can't replace the human touch to produce meaningful weight loss in obesity treatment, reports a new study. Giving people technology alone for the initial phase of obesity ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results